Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MicroRNAs (miRNAs/miRs) serve tumor promoting or suppressive roles in different human cancer types, including
glioma
; however, the regulatory underlying mechanism by which miR-599 affects
glioma
progression remains largely unknown. The aim of the present study was to investigate the expression of miR-599 in
glioma
, as well as the underlying regulatory mechanism. Reverse transcription-quantitative polymerase chain reaction and western blot analysis were used to examine mRNA and protein expression, respectively. MTT, wound healing and transwell assays were conducted to study cell proliferation, migration and invasion, respectively. A dual-luciferase reporter gene assay was used to confirm the targeting association between miR-599 and
Ras-related protein Rab-27B
(hereafter RAB27B). In the present study, miR-599 expression was observed to be significantly downregulated in human
glioma
tissues and cell lines, when compared with normal brain tissues and normal human astrocyte cells, respectively. Low miR-599 expression was significantly associated with
glioma
progression. Ectopic expression of miR-599 caused a significant reduction in the proliferation, migration and invasion of U-87MG Uppsala and U251 cells. Bioinformatics analysis and dual-luciferase reporter gene assay data identified that RAB27B was a direct target gene of miR-599. The mRNA and protein expression of RAB27B was significantly downregulated following miR-599 overexpression in U-87MG Uppsala and U251 cells. Rescue experiments demonstrated that RAB27B rescued the miR-599-induced inhibition of
glioma
cell growth, migration and invasion. In addition, RAB27B expression was significantly upregulated in
glioma
tissues and cell lines, and the expression levels of RAB27B were inversely correlated with miR-599 levels in
glioma
tissues; therefore, the present study demonstrated that miR-599 exerts a tumor-suppressive role in
glioma
progression by targeting RAB27B, indicating that miR-599 may be used as a potential candidate for
glioma
treatment.
...
PMID:MicroRNA-599 suppresses glioma progression by targeting RAB27B. 2996 97